Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: relation to disease activity and effect of chemotherapy.

Hasselbalch, H; Junker, P; Hørslev-Petersen, K; Lisse, I; Bentsen, K D

Hasselbalch, H; Junker, P; Hørslev-Petersen, K; Lisse, I; Bentsen, K D.

Affiliation

Hasselbalch H; Department of Medicine, Gentofte University Hospital, Copenhagen, Denmark.

Am J Hematol ; 33(1): 18-26, 1990 Jan.

Article in En | MEDLINE | ID: mdl-2293759

Subject(s)

Collagen/blood; Peptide Fragments/blood; Primary Myelofibrosis/blood; Procollagen/blood; Acute Disease; Biomarkers; Chronic Disease; Female; Humans; Leukocyte Count; Male; Myeloproliferative Disorders/blood; Platelet Count; Primary Myelofibrosis/drug therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Collagen / Procollagen / Primary Myelofibrosis Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Am J Hematol Year: 1990 Document type: Article Affiliation country: Denmark Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links